Evidence map›Paper›PMID 17115952›Full record

ReviewThe Medical journal of Australia2006

Laboratory diagnosis of human seasonal and pandemic influenza virus infection.

Dominic E Dwyer, David W Smith, Michael G Catton, Ian G Barr

Abstract readReview
In one paragraph

Review in The Medical journal of Australia, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Novel respiratory infectious diseases in Korea.Yeungnam University journal of medicine · 2020
    Article
  4. Article
  5. [Influenza: special aspects in old age].Zeitschrift fur Gerontologie und Geriatrie · 2018
    Article
  6. Point-of-care diagnostics for respiratory viral infections.Expert review of molecular diagnostics · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Influenza diagnosis and vaccination in Poland.Respiratory physiology & neurobiology · 2013
    Review
  13. Article
  14. Article
  15. Article
  16. Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtyping.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2010
    Article
  17. Article
  18. Article
  19. Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dominic E DwyerCentre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia. dominic_dwyer@wmi.usyd.edu.au
David W Smith
Michael G Catton
Ian G Barr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laboratory diagnosis is important to distinguish influenza from other respiratory virus infections. It will be especially important in detecting the first cases of pandemic influenza. Good quality respiratory tract sampling is needed to maximise diagnostic yield in influenza infection. In the appropriate clinical setting, pandemic strain-specific nucleic acid testing is the initial test of choice for suspected pandemic influenza. It is more sensitive than virus isolation, and more sensitive and specific than serology, immunofluorescence and other antigen detection methods. Virus isolation is needed to monitor new influenza strains and for vaccine development. Analysis of influenza isolates is undertaken by the World Health Organization Global Influenza Surveillance Network. Monitoring for antiviral resistance will be needed with widespread use of neuraminidase inhibitors for treatment and prophylaxis during a pandemic.

Indexed as

Antibodies, ViralAustraliaDisease OutbreaksDNA, ViralHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesLaboratoriesRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionSeasonsSentinel SurveillanceWorld Health OrganizationAntibodies, ViralDNA, ViralInfluenza Vaccines

Identifiers

PMID17115952
PMCPMC7168388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.